Karen Visnaw

Subcutaneous sarilumab for the treatment of hospitalized patients with moderate to severe COVID19 disease: A pragmatic, embedded randomized clinical trial

R. Dhond, G. Doros, P. Monach, 2022, PloS one.

Implementation of documented and written informed consent for clinical trials of communicable diseases: Lessons learned, barriers, solutions, future directions identified during the conduct of a COVID-19 clinical trial

P. Monach, W. Branch-Elliman, S. Leatherman, 2021, Contemporary Clinical Trials Communications.

Patient- reported reasons for non-participation in a COVID-19 therapeutics clinical trial: Findings from a multi-center investigation

P. Monach, M. Brophy, C. Shannon, 2023, Contemporary Clinical Trials.